Consolidated figures · ₹ crore
| ₹ Cr | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 143 | 151 | 136 | 116 | 147 | 163 | 133 | 167 | 141 | 165 | 167 | 200 | |
| COGS | 58 | 67 | 50 | 42 | 43 | 63 | 52 | 77 | 59 | 68 | 76 | 102 |
| Gross profit | 85 | 83 | 87 | 74 | 104 | 101 | 80 | 89 | 82 | 97 | 90 | 98 |
| 88 | 83 | 93 | 88 | 97 | 93 | 107 | 91 | 100 | 86 | 88 | 92 | |
| -4 | -0 | -6 | -14 | 7 | 8 | -27 | -1 | -18 | 12 | 3 | 6 | |
| OPM % | -2.5% | -0.1% | -4.4% | -12.1% | 4.8% | 4.9% | -20.3% | -0.7% | -12.6% | 7.1% | 1.5% | 2.8% |
| Depreciation | 9 | 9 | 9 | 9 | 9 | 9 | 8 | 8 | 8 | 8 | 8 | 8 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 |
| 6 | 8 | 14 | 7 | 7 | 6 | 36 | 17 | 9 | 5 | 5 | 7 | |
| Profit before tax | -8 | -2 | -2 | -17 | 5 | 4 | -0 | 7 | -19 | 6 | -1 | 4 |
| Tax | 1 | 1 | -0 | -1 | 0 | -0 | 2 | 3 | -5 | 3 | -0 | 1 |
| Tax % | 6.6% | 33.3% | -6.1% | -6.9% | 1.1% | -1.4% | 4,875% | 39.6% | -26.9% | 40.1% | -20% | 38.4% |
| -8 | -2 | -2 | -16 | 5 | 4 | -2 | 4 | -14 | 4 | -1 | 2 | |
| PAT margin % | -5.8% | -1.5% | -1.5% | -13.7% | 3.2% | 2.7% | -1.5% | 2.4% | -9.9% | 2.4% | -0.6% | 1.1% |
| EPS (₹) | -1.4 | -0.4 | -0.2 | -2.6 | 0.8 | 0.7 | -0.3 | 0.7 | -2.3 | 0.7 | 0.1 | 0.4 |
| Results filing | — | — | — | — | — | — | — | Results filing for Jun 2025 | Results filing for Sep 2025 | Results filing for Dec 2025 | Results filing for Mar 2026 | Results filing for Jun 2026 |
| vs same quarter last year | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % | +36.1% | +30.6% | +5.8% | -10.4% | +3% | +8.6% | -2.9% | +44.1% |
As reported in NSE results XBRL. Segment result is before tax and finance costs.
Latest reported period · 30 Jun 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed |
|---|---|---|---|---|---|
| Vaccines | 134.67 | 7.47 | 912.03 | 331.64 | 580.39 |
| Formulations | 64.9 | -3.9 | 382.45 | 131.51 | 250.94 |
| -4.2% |
| +1% |
| +25.8% |
| +19.7% |
| PAT YoY % | -152.8% | -111.4% | — | -244.6% | — | — | — | — | -397.5% | -12.4% | — | -44.4% |
₹ crore by quarter